The COVID Project
Context, not an orderThis record is guidance or an announcement kept for context. It is not counted among the orders in force.
The record
- Jurisdiction
- United States (federal); Substance Abuse and Mental Health Services Administration
- Level
- Federal
- Authority
- 42 C.F.R. 8.11(h), 8.12(i)
- Issued
- 2021-11-18 Nov. 18, 2021
- Effective
- Effective upon expiration of the COVID-19 PHE, for one year (superseded by the final rule effective Apr. 2, 2024) (read as 2024-04-02)
- End
- 2024-04-02
- In force
- Apr. 2, 2024 to Apr. 2, 2024
- Limitation types
- Health care ordersOther
- Addressees
- opioid treatment programs
- State opioid treatment authorities
- Functions reached
- Character
- context
- Collection
- Other federal health agencies AGY-FED-HEALTH-OTHER
Operative words
On March 16, 2020, SAMHSA issued an exemption to Opioid Treatment Programs (OTPs) whereby a state could request 'a blanket exception for all stable patients in an OTP to receive 28 days of Take-Home doses of the patient's medication for opioid use disorder.'... Therefore, SAMHSA is pre-emptively granting OTPs an exemption, effective upon the expiration of the COVID-19 Public Health Emergency, and subject to the conditions identified below, from the unsupervised take-home medication requirements of 42 C.F.R. 8.12(i).
Enforcement
OTP certification conditions
Notes
Post-period instrument saved for its recital that the March 16, 2020 exemption remained in force throughout the emergency and for the continuation it granted.
Retrieval noteRendered from the Nov. 18, 2021 archived page with headless Edge. Cite it as context and cite the underlying order, statute or emergency rule it describes as the instrument. (Bulletins whose operative text imposes a mandatory duty on licensees under the regulator's own authority are excluded from this downgrade and listed separately for review.)).